B N Immunotheapeutics is categorized under Commercial Medical Research in Mountain View, CA and active since 2005.
B N Immunotheapeutics was established in 2005, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417112 by the NAICS.
If you are seeking more information, feel free to contact Brian Black, Manager at the company’s single location by writing to 2425 Garcia Avenue, Mountain View, California CA 94043 or by phoning (650) 681-4660. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | B N Immunotheapeutics |
Contact Person: | Brian Black, Manager |
Address: | 2425 Garcia Avenue, Mountain View, California 94043 |
Phone Number: | (650) 681-4660 |
Website Address: | bavarian-nordic.com |
Annual Revenue (USD): | Unknown |
Founded: | 2005 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 5417112 |
Share This Business: |
B N Immunotheapeutics was started in 2005 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Brian Black, Manager for inquiries that concern B N Immunotheapeutics by calling the company number (650) 681-4660, as your correspondence is most welcome. Additionally, the physical location of the single location of B N Immunotheapeutics can be found at the coordinates 37.427803,-122.097308 as well as the street address 2425 Garcia Avenue in Mountain View, California 94043.
For its online presence, you may visit B N Immunotheapeutics’s website at bavarian-nordic.com and engage with its social media outlets through on Twitter and on Facebook.